IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha. 2004

Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
Division of Immunoregulation, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, Japan.

The production of eotaxin, which is a critical mediator for airway inflammation, is inhibited by IFN-gamma. Here, we investigated the precise mechanisms underlying IFN-gamma-dependent inhibition of eotaxin production using mouse embryonic fibroblasts (MEF). MEF produced high levels of eotaxin in STAT6-dependent manner when they were cultured with both IL-4 and TNF-alpha. However, the eotaxin production by MEF was strongly inhibited by addition of IFN-gamma. Western-blotting analysis demonstrated that IFN-gamma downmodulated STAT6 phosphorylation induced by IL-4 and TNF-alpha. Moreover, IFN-gamma did not exhibit its inhibitory effect on both STAT6-phosphorylation and eotaxin production in MEF obtained from deficient mice in STAT1, a key molecule of IFN-gamma signaling. We also demonstrated that SOCS-1, a potent inhibitory molecule of IL-4 signaling, was induced by IFN-gamma in STAT1-dependent manner. This indicated that SOCS-1 might be involved in IFN-gamma-mediated STAT1-dependent inhibition of eotaxin production. In SOCS-1(-/-) MEF, IFN-gamma inhibited neither STAT6 phosphorylation nor eotaxin production induced by IL-4 and TNF-alpha. Conversely, retroviral transduction of SOCS-1 into MEF inhibited STAT6 phosphorylation and eotaxin production induced by IL-4 and TNF-alpha, in the absence of IFN-gamma. Thus, we demonstrated that IFN-gamma-induced inhibition of STAT6 phosphorylation and eotaxin production were mediated by SOCS-1 induced in STAT1-dependent manner.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
April 2001, Journal of immunology (Baltimore, Md. : 1950),
Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
July 2007, Journal of immunology (Baltimore, Md. : 1950),
Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
May 1999, Journal of immunology (Baltimore, Md. : 1950),
Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
May 1998, Neuroreport,
Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
December 1997, Journal of immunology (Baltimore, Md. : 1950),
Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
March 1989, Immunology,
Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
August 1992, International journal of immunopharmacology,
Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
June 2006, Biological & pharmaceutical bulletin,
Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
January 1991, European cytokine network,
Takeshi Sato, and Rumina Saito, and Takafumi Jinushi, and Takemasa Tsuji, and Junko Matsuzaki, and Toshiaki Koda, and Shin ichiro Nishimura, and Hidetsugu Takeshima, and Takashi Nishimura
February 2003, Clinical and experimental immunology,
Copied contents to your clipboard!